Skip to content
WealthTicker

BIOGEN INC

Held by 2 mutual fund schemes, ₹7.72Cr between them.

The largest single position is Motilal Oswal Nasdaq Q50 ETF (Motilal Oswal), which holds 2.8% of its portfolio in BIOGEN INC — ₹4.97Cr, or 64.4% of all the mutual fund money in this stock.

Schemes holding
2
MF money
₹7.72Cr
Largest weight
2.8%
P/E
—

Funds holding BIOGEN INC

2

Largest rupee position first. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.

FundCategoryWeightPositionFund size
Motilal Oswal Nasdaq Q50 ETFOther ETFs2.82%₹4.97Cr₹176.40Cr
Motilal Oswal S&P 500 Index FundIndex Funds0.06%₹2.75Cr₹4,581Cr

Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM. Nothing here is advice, and a stock being widely held is not an argument for owning it.

Funds buying and selling BIOGEN INC

In their latest monthly disclosure, 1 fund bought and 0 sold, judged by share count.

FundMoveWeightValue
Motilal Oswal Nasdaq Q50 ETFAdded2.36% → 2.82%₹26.73L

Frequently asked questions

Which mutual fund holds the most BIOGEN INC?

By rupee value, Motilal Oswal Nasdaq Q50 ETF from Motilal Oswal — ₹4.97Cr, at 2.8% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.

How many mutual funds hold BIOGEN INC?

2 schemes, holding ₹7.72Cr between them across the 2 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.

Does a fund holding BIOGEN INC make it a good investment?

No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.